Biological and clinical perspectives of tissue engineering for periodontal soft tissue augmentation
Year: 2026
Type: dissertation
Abstract: Background Mucogingival surgery, a treatment for soft tissue deficiencies, typically relies on autologous grafts as the gold standard. While soft tissue substitutes (STS) have emerged as alternatives to minimize patient morbidity, none currently match the efficacy of autologous grafts. The integration of specific cells, scaffolds, and signalling molecules is essential for achieving effective tissue regeneration and forms the foundation of tissue engineering. This research program aimed to provide both biological and clinical insights into tissue-engineered augmentation of periodontal soft tissue. Methods Four research projects were designed to address the overall research question and specific aims. Project 1: A Systematic Review and Meta-Analysis of all available evidence on STS use in soft tissue augmentation procedures around dental implants. This project aims to critically assess the current evidence and determine which STS could potentially serve as a viable alternative to autologous grafts, traditionally regarded as the gold standard (Chapter 4). Project 2: A pre-clinical study evaluating and comparing the angiogenic potential of various STS using the ex-ovo chick chorioallantoic membrane (CAM) assay to examine angiogenic potential of six different STS scaffolds (Chapter 5). Project 3: A pre-clinical study using the in-ovo CAM assay (Chapter 6) to elucidate the scaffolds’ angiogenic capabilities and their interactions with biological factors such as cell-based tissue engineering and growth factors. Key assessments for projects 2 and 3 included morphological characterization via SEM, angiogenic potential using stereomicroscopy, histological data, and vascularization analysis via optical coherence tomography (OCT). Project 4: OCT data were processed using OCTAVA software for enface images and the IKOSA-AI program for AI-enhanced cross-sectional imaging, capturing metrics such as vessel area density, vessel length, and branch point density (Chapter 7). Results The appraisal of existing evidence confirmed that autologous grafts remain the gold standard for mucogingival treatment. However, xenogeneic collagen matrices (XCM) and acellular dermal matrices (ADM) demonstrated potential as collagen-based sca]olds for soft tissue augmentation over a 12-month follow-up period. Despite their inferior performance compared with autologous grafts, these alternatives showed promising clinical potential, highlighting the need for further biomaterial optimization. Angiogenesis played a pivotal role in demonstrating the regenerative potential of STS as alternatives to autologous grafts. Findings from the ex-ovo CAM assay revealed that both collagen matrix (CM) and acellular dermal matrix (ADM) stimulated neovascularization,with ADM demonstrating more favourable angiogenic outcomes over a 3-day implantation period. The integration of biological molecules to support the triad of tissue engineering emerged as a promising strategy in regenerative medicine. Collagen-based sca]olds demonstrated the potential to enhance angiogenesis through tissue-engineering approaches. In subsequent experiments, six collagen-based sca]olds were evaluated in combination with either micrografts or injectable platelet-rich fibrin (i-PRF) over a seven- day implantation period using the in-ovo CAM assay, with vascularization analysis conducted using IKOSA software. Findings indicated that XCM, VXCM, and AADM were the most e]ective sca]olds when combined with both micrografts and i-PRF. In contrast, porcine-derived ADM (M) was e]ective only when combined with i-PRF. The XCF combination influenced vessel quality, while PADM(N) demonstrated independent optimization potential. Smooth muscle actin (SMA) staining showed that biological molecules penetrated the middle section of XCM, whereas other sca]olds enhanced cell counts predominantly within the superficial section or across the total sca]old area. The application of machine learning and artificial intelligence (AI) provided rapid and precise assessment of vascularization outcomes. Optical coherence tomography (OCT), combined with OCTAVA and IKOSA-AI software, yielded findings comparable to histological imaging, thereby creating the potential for near real-time imaging assessment. Conclusions The findings of this thesis suggest that XCM and ADM may represent promising substitutes for autologous grafts in periodontal soft tissue augmentation. The study highlighted the importance of biomaterial characteristics, including source, structural architecture, and biodegradability, in influencing biological and clinical outcomes. Furthermore, the incorporation of micrografts or i-PRF into collagen-based sca]olds enhanced angiogenesis in selected materials, although some sca]olds demonstrated limited integration with biological molecules. The integration of AI and machine learning with OCT imaging o]ers promising opportunities for rapid and potentially real-time assessment of tissue augmentation procedures. However, further validation through well-designed randomized controlled trials is required before these approaches can be translated into routine clinical practice.
Author: Kuswandani, Sandra Olivia
Language: English
Subfield: Oral Surgery
Field: Dentistry
Domain: Health Sciences
Keywords: periodontal plastic surgery, autograft, xenogeneic collagen matrix, acellular dermal matrix, angiogenesis, neovascularization, chorioallantoic membrane assay, optical coherence tomography, vessel density, growth factors, dental implants, cell-based tissue engineering, biomaterials, periodontal regeneration
Open Access status: green
OpenAlex ID: W7219989463
